|
C20ORF43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.774500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.665900E-02 |
| Normal-vs-Stage2 |
9.030200E-02 |
| Normal-vs-Stage3 |
9.356800E-01 |
| Normal-vs-Stage4 |
2.059600E-01 |
| Stage1-vs-Stage2 |
7.786000E-01 |
| Stage1-vs-Stage3 |
2.125000E-01 |
| Stage1-vs-Stage4 |
7.016600E-01 |
| Stage2-vs-Stage3 |
2.463000E-01 |
| Stage2-vs-Stage4 |
7.996200E-01 |
| Stage3-vs-Stage4 |
3.368600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.766160E-01 |
| Normal-vs-AfricanAmerican |
3.701900E-02 |
| Normal-vs-Asian |
3.549400E-01 |
| Caucasian-vs-AfricanAmerican |
3.059600E-01 |
| Caucasian-vs-Asian |
5.082200E-01 |
| AfricanAmerican-vs-Asian |
6.573800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.152490E-02 |
| Normal-vs-Female |
8.472000E-01 |
| Male-vs-Female |
2.115700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.630950E-01 |
| Normal-vs-Extreme_Weight |
2.378400E-02 |
| Normal-vs-Obese |
8.576800E-01 |
| Normal-vs-Extreme_Obese |
2.773800E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.035600E-01 |
| Normal_Weight-vs-Obese |
2.564200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.662610E-01 |
| Extreme_Weight-vs-Obese |
7.860100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.240800E-01 |
| Obese-vs-Extreme_Obese |
2.844300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.821400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.975600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.937700E-03 |
| Normal-vs-Age(81-100Yrs) |
7.962200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.959000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.918810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.106180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.256100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.752100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.165200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.406200E-02 |
| Normal-VS-Type2 PRCC |
5.697900E-02 |
| Normal-VS-KIRP CIMP |
1.336190E-01 |
| Normal-VS-Unclassified PRCC |
2.011400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.584600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.600400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.285600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.108200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.376000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.552500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.431900E-02 |
| Normal-vs-N1 |
7.635800E-01 |
| Normal-vs-N2 |
2.790600E-01 |
| N0-vs-N1 |
3.311200E-01 |
| N0-vs-N2 |
9.946000E-01 |
| N1-vs-N2 |
6.311200E-01 |
|
|
